Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2012: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2010: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Research Abstract |
In this study, we examined whether non-cytocidal helper T cells could be converted into cytotoxic T lymphocytes (CTL) via gene transferring, in order to investigate the possibility that conference of cytotoxicity to tumor antigen specific helper T cells could be utilized to eradicate tumors. It was suggested transfection of either one gene of the two T-box molecules, Eomesodermin and T-bet, could activate both of the two cytolytic pathways of CD8+CTLs and conferred the cytolytic activity to helper T cells. Microarray analyses revealed that Eomes could induce several other CTL-specific genes which may be involved in shaping characteristics of CD8+CTLs. Currently, Eomes-Tg line is being established for further detailed analyses for the clinical use of this protocol for tumor treatment.
|